Yearly zoledronic acid in postmenopausal osteoporosis.
作者信息
de Nijs Ron N J, Westgeest Antonius A A
出版信息
N Engl J Med. 2007 Aug 16;357(7):711; author reply 714-5. doi: 10.1056/NEJMc071514.
PMID:17699824
Abstract
摘要
相似文献
1
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):711; author reply 714-5. doi: 10.1056/NEJMc071514.
2
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5.
3
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):712-3; author reply 714-5.
4
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):713-4; author reply 714-5.
5
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312.
6
A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther. 2007 Nov 5;49(1273):89-90.
7
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):713; author reply 714-5.
8
[Osteoporosis and bisphosphonates].
Z Rheumatol. 2007 Dec;66(8):713-5. doi: 10.1007/s00393-007-0227-8.
9
Annual zoledronic acid for osteoporosis.
Drug Ther Bull. 2008 Dec;46(12):93-6.
10
Treatments for osteoporosis - looking beyond the HORIZON.
N Engl J Med. 2007 May 3;356(18):1878-80. doi: 10.1056/NEJMe078051.
引用本文的文献
1
Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.
Clin Interv Aging. 2008;3(4):611-27. doi: 10.2147/cia.s2496.
2
Zoledronic acid: a review of its use in the treatment of osteoporosis.
Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007.
Zotero 插件